Minerva Neurosciences Inc (NERV) — Capital Reinvestment Ratio
Latest as of December 2017:
0.02x
Minerva Neurosciences Inc (NERV) has a Capital Reinvestment Ratio of 0.02x as of December 2017, meaning it reinvests 0% of its operating cash flow ($3.09 Million) in capital expenditures ($52.40K). See cash generation quality of Minerva Neurosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
$3.09 Million
USD
Capital Expenditures
$52.40K
USD
Data as of
Dec 2017
Most recent filing
Minerva Neurosciences Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Minerva Neurosciences Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Minerva Neurosciences Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Minerva Neurosciences Inc from 2017 to 2017. For live market cap and broader valuation context, see Minerva Neurosciences Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.02x | $3.09 Million | $52.40K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow